SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
乌托邦
Lv5
830 积分
2021-12-16 加入
最近求助
最近应助
互助留言
Osimertinib after Chemoradiotherapy in Stage III EGFR -Mutated NSCLC
1天前
待确认
Folinic Acid to Prevent Pemetrexed-Associated Neutropenia After Intrathecal Administration: A Quick Win
6天前
已完结
Befotertinib: First Approval
20天前
已完结
Successful osimertinib rechallenge after severe thrombocytopenia caused by osimertinib combined with sitagliptin: a case report
22天前
已完结
Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
24天前
已完结
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
24天前
已完结
Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
1个月前
已完结
Efficacy and safety of re-challenging 160 mg furmonertinib for advanced NSCLC after resistance to third-generation EGFR-TKIs targeted agents: A real-world study
2个月前
已完结
Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial
2个月前
已完结
Overall Survival From the EORTC LCG-163 APPLE Trial of Osimertinib Versus Gefitinib Followed by Osimertinib in Advanced EGFR-Mutant Non–Small-Cell Lung Cancer
2个月前
已完结
没有进行任何应助
感谢,速度真快
4天前
感谢,速度真快
20天前
点赞,速度真快
24天前
感谢,帮大忙了
24天前
感谢,么么哒
1个月前
感谢,帮大忙了
2个月前
感谢,速度真快
2个月前
点赞,速度真快
3个月前
感谢,帮大忙了
3个月前
感谢,速度真快
3个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论